Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Porzsolt

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Langenbecks Archiv Fur Chirurgie. Supplement II, Verhandlungen Der Deutschen Gesellschaft Fur Chirurgie. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1990
[Advantages and problems of interdisciplinary tumor conferences]H Heimpel, E Loetzke, F Porzsolt
Urologia Internationalis|January 1, 1974
[Alterations in serum proteins in patients with hypernephroma (author's transl)]K H Bichler, F Porzsolt, C Kirchner
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 13, 2012
[Clinical economics: a concept to optimize healthcare services]F Porzsolt, K Bauer, D Henne-Bruns
Zentralblatt Fur Chirurgie|January 29, 2013
[Validity of Recommendations for Secondary Prevention of Colon Cancer]F Porzsolt, D Ittner, D Henne-Bruns
Deutsche Medizinische Wochenschrift (1946)|August 25, 1972
[Proteinuria after physical exercise]K H Bichler, F Porzsolt, K Naber
Lancet (London, England)|August 30, 1986
Eradication by alpha-interferon of one clone in biclonal hairy cell leukaemiaA Raghavachar, C R Bartram, F Porzsolt
Zentralblatt Fur Chirurgie|April 17, 2008
[Lay assessment of health care services using therapy for rectal cancer as an example]M Kornmann, F Porzsolt, D Henne-Bruns
Urologia Internationalis|January 1, 1973
[Detection of tumorantigens of hypernephroma (author's transl)]K H Bichler, C Kirchner, F Porzsolt
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about itD Rothenbacher, M P Lutz, F Porzsolt
Onkologie|February 1, 1987
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c]D Messerer, F Porzsolt, J Hasford, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Langenbecks Archiv Fur Chirurgie. Supplement II, Verhandlungen Der Deutschen Gesellschaft Fur Chirurgie. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1990
[Advantages and problems of interdisciplinary tumor conferences]H Heimpel, E Loetzke, F Porzsolt
Urologia Internationalis|January 1, 1974
[Alterations in serum proteins in patients with hypernephroma (author's transl)]K H Bichler, F Porzsolt, C Kirchner
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 13, 2012
[Clinical economics: a concept to optimize healthcare services]F Porzsolt, K Bauer, D Henne-Bruns
Zentralblatt Fur Chirurgie|January 29, 2013
[Validity of Recommendations for Secondary Prevention of Colon Cancer]F Porzsolt, D Ittner, D Henne-Bruns
Deutsche Medizinische Wochenschrift (1946)|August 25, 1972
[Proteinuria after physical exercise]K H Bichler, F Porzsolt, K Naber
Lancet (London, England)|August 30, 1986
Eradication by alpha-interferon of one clone in biclonal hairy cell leukaemiaA Raghavachar, C R Bartram, F Porzsolt
Zentralblatt Fur Chirurgie|April 17, 2008
[Lay assessment of health care services using therapy for rectal cancer as an example]M Kornmann, F Porzsolt, D Henne-Bruns
Urologia Internationalis|January 1, 1973
[Detection of tumorantigens of hypernephroma (author's transl)]K H Bichler, C Kirchner, F Porzsolt
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about itD Rothenbacher, M P Lutz, F Porzsolt
Onkologie|February 1, 1987
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c]D Messerer, F Porzsolt, J Hasford, et al.
Pageof 14